Drug Screening Center

Drug Screening Center

The Drug Screening Center at ATLATL is built to help teams identify hits, validate targets, and generate proof-of-concept data faster.
The platform integrates automation, advanced detection technologies, and biologically relevant models into a single, on-site execution environment. Scientists can rapidly design and run experiments with minimal setup, enabling high-throughput, reproducible workflows and fast iteration.
By combining cell-based assays, organoid models, high-content imaging, and molecular analysis, the platform supports end-to-end workflows—from assay development and screening to hit validation and mechanism-of-action studies. Located within ATLATL’s bio-hubs, teams work side-by-side with technical experts, accelerating decision-making and reducing development risk.

Core Capabilities:

High-Throughput Screening (HTS)
Automated compound screening for rapid hit identification with high reproducibility.
Cell-Based & Organoid Assays
Functional and phenotypic assays using 2D cell systems and advanced 3D models.
Target Validation & MoA
Molecular and cellular analysis to confirm targets and understand mechanisms.
Biomolecular Interaction Analysis
SPR-based, label-free analysis of binding affinity, specificity, and kinetics.
Data Analysis & Hit Advancement
Integrated data processing and support for lead selection and early optimization.

Equipments:

ZUOFEI Automatic Liquid Handing Solution

Revvity Janus G3 Workstation

Revvity Zephyr Workstation

MD SpectraMax ABS Plus Microplate Reader

MD SpectraMax i3x Multi-Mode Microplate Reader

Revvity EnVision™ Microplate Reader

Revvity Operetta CLS High Content Imaing System

Tecan Spark Cyto Plate Reader

Thermo 7500 Real-Time PCR System

Roche LightCycler® 480 Real-Time PCR System

R&D Applications:

Small Molecule Discovery

High-throughput screening and dose–response profiling

Biologics & Antibody Development

Binding, potency, and functional validation

Oncology Drug Screening

Tumor models, co-culture systems, and organoids

Immunology & Inflammation

Immune cell assays and cytokine profiling

Gene & RNA Therapeutics Screening

CRISPR, siRNA, mRNA, and viral vector evaluation

Toxicology & Safety Assessment

Early detection of cytotoxicity and off-target effects

滚动至顶部